The Hindu Morning Digest, August 5, 2025
Less than a week after he announced a 25% tariff on imports from India 'plus a penalty', U.S. President Donald Trump on Monday (August 4, 2025) once again raised the issue of India buying oil from Russia and profiting from it. He stated that he would be 'substantially' raising the tariff 'paid by India to the USA'. The Indian government hit back at Mr. Trump's statements and also criticism from European countries on India's trade with Russia, saying that such 'targeting of India' was 'unjustified and unreasonable'. In a statement, the government pointed out that not only did the U.S. encourage such trade previously, both the European Union and the U.S. continue to actively trade with Russia in excess of the amount that India does.
Netanyahu to convene cabinet as Israel decides next steps in Gaza after ceasefire talks collapse
Benjamin Netanyahu will convene his security cabinet this week to decide on Israel's next steps in Gaza following the collapse of indirect ceasefire talks with Hamas, with one senior Israeli source suggesting more force could be an option.
Bihar leaders find SIR draft rolls 'difficult' to compare
Opposition parties in Bihar on Monday (August 4, 2025) accused the Election Commission of India (EC) of 'deliberately' making it 'difficult' for them to compare the electoral rolls issued ahead of the Lok Sabha election in January 2024 with the draft rolls published on August 1 as part of the Special Intensive Revision (SIR), even as the poll panel said that no party has filed any claim and objection for addition or deletion of names, yet.
Unease prevails in J&K ahead of Article 370 abrogation anniversary
With security heightened, unease gripped Jammu and Kashmir on Sunday (August 3, 2025), ahead of the sixth anniversary of the abrogation of the special provisions of Article 370 in the erstwhile State. While National Conference (NC) leader and Chief Minister Omar Abdullah of the National Conference (NC) expressed optimism, the Opposition Peoples Democratic Party (PDP) observed 'a 150-minute blackout' on the occasion.
BJP raises spectre of 'political Islam' infiltrating Church in Kerala
The BJP has raised the spectre of 'political Islam' infiltrating the Church in Kerala. The party's State vice-president Shone George told a news conference on Monday (August 4, 2025) that radical Islamists, beholden to the Social Democratic Party of India (SDPI) and Jamaat-e-Islami, had infiltrated Church protests in sizeable numbers, including those led by bishops, across the State.
IND vs ENG fifth Test: Mohammed Siraj does the star turn as India levels series with a stunning win
Mohammed Siraj couldn't hold back his tears as Dhruv Jurel ran in and hugged him. Shubman Gill stood quietly for a moment, looking up at the sky, before the teammates rushed towards him to celebrate. Prasidh Krishna waved towards the packed stands as the tricolour fluttered high. It seemed after 25 days of riveting action, the best was saved for the last as India came from behind to pull off a six-run win against England in the fifth Test and draw the series 2-2.
Sheikh Hasina completes a year in exile in India as Bangladesh plans election in 2026
A year after then Prime Minister of Bangladesh Sheikh Hasina fled Dhaka and arrived in India, she remains in regular contact with Awami League party leaders in Bangladesh and in exile around the world. Her exact whereabouts in the present and political future, however, remain a mystery, as New Delhi has discouraged her and her supporters from overt political activity. Ms. Hasina now faces a number of charges over corruption, human rights violations and even war crimes during her tenure, making her return to Dhaka unlikely at present. Meanwhile, after saying he would not stop the Awami League from standing for elections expected to be held in mid-February 2026, Bangladesh interim government's Chief Adviser Muhammad Yunus has banned the erstwhile ruling party and its students' wing, making it impossible for them to participate.
Skeletal remains found at new location near site no. 11 in Dharmasthala
The Special Investigation Team (SIT) probing the alleged burials at Dharmasthala found a few skeletal remains at a new location, which was near site no. 11, in the temple town, on Monday. As the SIT was preparing to dig at site no. 11, which was among the 13 burial sites identified by the 50-year-old complainant, he suggested that a site at a new location nearby also be dug. The SIT personnel found a human skull and a few bones of a human body at the new site in the Banglegudde area.
Israeli ex-security chiefs urge Trump to help end Gaza war
Hundreds of retired Israeli security officials, including former heads of intelligence agencies, have urged U.S. President Donald Trump to pressure their own government to end the war in Gaza. 'It is our professional judgement that Hamas no longer poses a strategic threat to Israel,' the former officials wrote in an open letter shared with the media on Monday.
Lok Sabha disrupted as Opposition seeks debate on Bihar SIR
Parliament did not function on Monday (August 4, 2025) with Opposition parties disrupting the Lok Sabha over demands for a discussion on the Special Intensive Revision (SIR) of electoral rolls in Bihar. The Rajya Sabha was adjourned as a mark of respect for member Shibu Soren, who passed away.
Rahul Gandhi to begin yatra covering 30 districts in Bihar from August 17
The Leader of the Opposition in the Lok Sabha Rahul Gandhi will set out on the 'Matdata Adhikar (voters' rights) Yatra' in Bihar in three phases covering 30 districts from August 17. The yatra, originally scheduled to begin on August 10, has been 'postponed by a week' following the death of Jharkhand Mukti Morcha (JMM) leader Shibu Soren, Congress spokesperson Asit Nath Tiwari told The Hindu.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Economic Times
19 minutes ago
- Economic Times
Eris Lifesciences eyes ‘good' share in semaglutide generics, says COO
Mr. Krishnakumar Vaidyanathan, Executive Director & Chief Operating Officer Eris Lifesciences looks to leverage its experience in integrated diabetes portfolio to take a lead among the first wave of generic semaglutide anti-diabetic and weight-loss drugs to hit the market early next year, a top official said. The company is looking at a 'good' share of the market, Krishnakumar Vaidyanathan, executive director and chief operating officer of Eris Lifesciences, told ET in an interaction. Semaglutide is the active ingredient in Novo Nordisk's blockbuster drugs Wegovy and Ozempic. Its patent in India will expire in March 2026. 'We are gearing up to be among the first to enter the market post loss of exclusivity,' Vaidyanathan said. 'We expect the overall market for GLP-1 at the end of the first 12 months (after the loss of exclusivity) to be at least 10 million units… And we expect to get a good share of the market.' Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Eris Lifesciences' existing diabetes portfolio includes orals, insulin and GLP-1 in the form of liraglutide. Its network of field representatives, patient connect and service platform in this space gives the firm an advantage over others, Vaidyanathan said. 'We do this day in and day out because of insulin. That gives us the confidence that we'll be able to step this up for GLP-1 as well.'Globally, the GLP-1 market is dominated by Eli Lilly and Novo Nordisk, which are also the two biggest insulin companies in the world. 'Being successful and big in the insulin market provides a huge tailwind when it comes to selling GLPs,' Vaidyanathan said. 'We have combined service with technology and product to create a winning combination in insulin and GLP therapy entry is not any different, which also requires a lot of patient education over and above the service on using the pens,' he said. 'We have an integrated diabetes portfolio because we currently sell GLP-1 in the form of liraglutide.' Dr Reddy's Labs, Sun Pharmaceutical Industries, Cipla, Mankind Pharma, Torrent Pharmaceuticals, and Zydus Lifesciences are also among Indian drugmakers readying to launch generic semaglutide next year. Eris Lifesciences launched liraglutide, a once-a-week GLP-1 product, last September. 'We have taken very good market shares in all the other LOE (loss of exclusivity) opportunities that we have seen in diabetes,' Vaidyanathan said. 'We have taken market ranks of 1 to 5 in each one without exception – vildagliptin, sitagliptin, linagliptin, dapagliflozin and empagliflozin. That gives us the confidence that we should be getting a fair share of the market.' Vishal Manchanda, pharma analyst at brokerage Systematix Group, said its full portfolio of anti-diabetes drugs to offer to diabetologist, spanning all oral and injectable options, should give Eris Lifesciences 'a strong positioning in a market where the large pharma majors like Sun, Lupin, Dr Reddy's, Cipla, Mankind and Zydus come in with their dominant brand presence.'
Hans India
21 minutes ago
- Hans India
Vedanta continues winning street confidence: Brokerages forecast strong earnings ahead
New Delhi: Major global and Indian brokerages remain optimistic on Vedanta Ltd's performance for FY26, citing stronger LME pricing trends, cost discipline, deleveraging, and a resilient aluminium business among the key growth drivers. These firms have also taken note of the several growth projects scheduled for commissioning or completion in the next few quarters. JP Morgan noted that Vedanta's first quarter consolidated EBITDA was largely in line with estimates, with key segments such as aluminium, oil and gas, and power faring better than its expectations, leading to an overall segmental EBITDA beat. On the earnings trajectory for the current and next fiscal, the firm expects various ongoing initiatives at Vedanta to aid growth. "Vedanta's capacity expansion journey in the aluminium business as well as vertical integration should bring cost advantages. LME prices have also bottomed out and should continue to move higher into FY26-27, likely aiding earnings growth." Echoing similar views on LME prices and its potential benefit, Citi Research cited that Vedanta's parent (Vedanta Resources) leverage is at comfortable levels. It listed potential upside in medium-term aluminium LME prices, lower cost, and the demerger as another positive for Vedanta, while adding that aluminium globally has a limited supply growth. Mumbai-based Nuvama Institutional Equities expects Vedanta to deliver quarter-on-quarter EBITDA growth in Q2. "Q2FY26 EBITDA is likely to increase 10 per cent-plus quarter-on-quarter on the back of higher prices and lower aluminium cost of production. Major aluminium projects are likely to be commissioned in Q2FY26. We reckon net debt/EBITDA ex-Hindustan Zinc shall fall to 1.7x by FY26-end, compared to 2.7x in FY25. Demerger of the business is likely to be concluded in Q4FY26," the firm said in its report. The brokerage expects Vedanta's all major projects except coal blocks to be likely commissioned in the current fiscal, providing volume growth and cost reduction visibility for the company. UK-based Investec stated in its post-earnings report that Vedanta is a key beneficiary of depreciation in the Indian Rupee. Other near-term positives listed by the firm include declining alumina prices and the company offering attractive yields. The firm has retained its buy recommendation on Vedanta. Research firms like Kotak Institutional Equities and IIFL have cited factors like cost efficiencies and deleveraging at both Vedanta Ltd and its parent Vedanta Resources as beneficial factors. Vedanta's adjusted profit after tax jumped 13 per cent year-on-year to Rs 5,000 crore. The company clocked its highest-ever first-quarter EBITDA of Rs 10,746 crore, which was up 5 per cent year-on-year.
Hans India
21 minutes ago
- Hans India
UP CM Adityanath, BSP chief Mayawati express grief over Satyapal Malik's death
Lucknow: Uttar Pradesh Chief Minister Yogi Adityanath and BSP chief Mayawati on Tuesday expressed grief over the death of Satyapal Malik, the former governor of Jammu and Kashmir. In a post on X in Hindi, CM Adityanath said, "The demise of former governor Satyapal Malik ji is extremely sad. Humble tribute! My condolences are with the bereaved family. I pray to God to grant salvation to the departed soul and strength to the bereaved family to bear this sorrow. Om Shanti!" Condoling the death of Malik, BSP chief Mayawati in a post on X in Hindi said, "The news of the death of Shri Satyapal Malik, who was the governor of many states, including Jammu and Kashmir, today is very sad. My deepest condolences to his bereaved family and all his supporters. May nature give them the strength to bear this sorrow." Malik (79) died on Tuesday at a hospital in New Delhi after a prolonged illness, his personal staff said. He was 79. Malik, who had also held the positions of governor of Goa, Bihar, Meghalaya, and Odisha, besides being a member of the Lok Sabha and the Rajya Sabha in his long political career, died at 1.12 pm at the Ram Manohar Lohia hospital in New Delhi. He was in the ICU of the hospital for a long time, getting treatment for various ailments, the staff said. In his gubernatorial role in Jammu and Kashmir, Malik oversaw the abrogation of Article 370 and the bifurcation of the state into two Union Territories on August 5, 2019. Coincidentally, he took his last breath on the sixth anniversary of the Centre's move. Malik attracted a lot of controversy after alleging that he was offered a bribe to clear files of two major projects in Jammu and Kashmir and questioned the BJP-led central government over issues related to farmers and the Pulwama terror attack, among others.
